Portfolio
Zernike Group's business development methodology is that it undertakes the evaluation of technology by first looking at the market. This approach has seen Zernike Group establish over 500 start-ups in the past 20 years. The Group measures success by the start-up reaching mezzanine financing or venture capital or an IPO. Over the past 8 years, zero stage funds or seed fund managed by Zernike have achieved an annual return of >8% (on average) compared to the European Union average of minus 4%.
BioPartner Start-up Ventures
BioPartner Start-up Ventures is a start-up venture fund established at the end of 2000 by the Ministry of Economic Affairs of the Netherlands, aimed at accelerating the Dutch life science industry by improving the entrepreneurial climate for bio-starters and bio-business, and by removing the obstacles identified for bio-entrepreneurs such as, lack of information, financing, laboratory equipment and lab space. The fund offers stimulation of Life Sciences in the Netherlands and risk capital fund for Life Science start-ups, investing in shares possibly combined with a subordinated loan.
BioPartner Start-up Venture Participations
AM Pharma
Development of high quality anti-microbial compounds, as an alternative for the current generation of antibiotics.
BioHill/Ingeny
Their focus is the mutation detection area. Development of instruments and primers to detect mutations and polymorphisms in DNA.
Boost
Focusing on the commercial exploitation of a range of immune response modifiers. From 2009 its products shall be offered as R&D products and also as adjuvant to the therapeutic and veterinary vaccine industry.
Care4Cure
An internet portal for the medical field. It aims to provide service, access to databases, training courses, support in business and practice management, as well as career development.
CatchMabs
Development of the iMab® technology (industrial Molecular affinity bodies), small designer proteins that can bind target molecules with both high affinity and high specificity, thus providing a single step purification for large scale processes in pharmacy and food processing industries.
Disindi
Development of a non-invasive breathing indicator.
Dynomics
Focus on the diagnosis and classification of leukaemia and malignant lymphomas as well as on the evaluation of treatment effectiveness during follow-up. Access to a large cell bank of frozen and well-documented leukaemia samples and the associated clinical files.
EcoDeco
Regenerate seawater and preserve plankton in closed systems in a completely natural way. Aquatic organisms that were hardly or not at all maintainable so far can now be kept alive, they will even procreate.
EverDry
Development and commercialisation of a wide range of natural fibre, chemical free, moisture free, absorbent and environmentally friendly textile products that are especially designed to have a wide array of applications in the area of incontinence.
Exenta BV
Development of compounds to add in food for cattle, instead of antibiotics.
File-Reg
File-Reg.com is the online registration service to prove copyright worldwide with registration servers on different continents.
FlexGen
Provide the research community with a bench top instrument capable of synthesizing 'Arrays-on-Demand', named FlexArrayer, which uses a laser-guided, spot-by-spot photochemical oligonucleotide synthesis process based on our patented virtual masking technology.
Genoclipp
By performing Contract Research, GenoClipp is able to render turnover in a very early stage and also to partly earn back R&D costs for its proprietary technology.
Gozon BV
Development of systems for purification of waste-water.
Intra-Vasc
Specialized in the development, manufacturing and marketing of disposable intra-vascular blood pumps and large bore thin walled catheters.
Krystalik BV
Development of bacterial liquid products for purification of waste-water.
MagnaMedics
MagSi-Streptavidin consists of silica nanospheres that encapsulate fine magnetic particles. The surfaces of these spheres (beads) are coated with the binding protein streptavidin, enabling target molecules, blood cells, DNA or bacteria to be captured, isolated and further treated. MagSi streptavidin beads are ideally suited for use in automated processes and are available in sizes ranging from 30 nm to 300 µm.
Martil Instruments
Develops a sophisticated mobile intravenous system to register haematological and cardiological parameters in-line for diagnostics and guidance of patient care.
Mosaic Systems
Specializing in large scale biologics separation and purification for Agri, Food Ingredients, and (Bio)Pharmaceuticals. Mosaic Systems has solved the through-put limitations providing a 4 to more than 50 times higher productivity.
Ovactis BV
Specialized in developing and providing functional ingredients for the food industry, pharmaceutical industry and cosmetics.
Pathofinder
Nucleic acid diagnostics company specialized in the development and commercialization of a new generation of molecular diagnostics.
PharmaKey
Modification of protein-hormones (cytokines). This approach is based on a chemical modification platform technology, resulting in three synergetic interactive platform applications.
PhotoBioChem
Inactivating micro-organisms in blood and on surfaces through the use of photo-dynamic molecules without damaging the surrounding cells.
PickCell BV
Development and sales of antibody products for cell biology and immunohistology research.
Podiceps
Start-up developing automated cancer screening systems based on a novel, widely usable proprietary technology for the detection of tumour cells.
Polyganics
Developing, manufacturing and commercializing bioresorbable health care products where the soft and semirigid properties and the controlled bioresorbability of their materials offer a strong and competitive medical advantage.
Polyvation/ Innocore
A drug delivery company serving the medical device and pharmaceutical industry with its advanced biodegradable polymeric drug delivery systems. They develop tailor-made drug delivery systems with desired release profiles and release rates, based on biodegradable SynBiosys™ multi-block copolymer platform.
Profibrix
Aims to create, develop and market new and innovative healthcare products, based on the unique properties of human fibrinogen.
ProSensa
Dedicated to the commercialization of products for the healthcare market based on RNA-based therapeutics. ProSensa has currently a collaborative effort towards developing a therapy for Duchenne Muscular Dystrophy.
Proxy Laboratories
An independent Quality Control laboratory offering many services to the international life sciences industry.
River Diagnostics
Develops and markets innovative instrumentation for in vivo measurements of skin composition on a microscopic scale. Information on skin composition is measured using River Diagnostics’ specialized equipment with depth resolution of 5 µm and the highest sensitivity available.
Solea
Development of a breeding system for sole.
Syntarga
Dedicated to creating value by developing unique & proprietary linker chemistries, which connect (anticancer) drug molecules to a (tumor)targeting peptide or antibody. These proprietary linker technologies allow bioconjugates (e.g., antibody-drug conjugates) that fulfil to all requirements of successful drug targeting.
Telemetronics
Developing animal friendly radio telemetry systems that enable bio-medical researchers and care takers of valuable animals to monitor on-line animal health parameters such as body temperature, heart rate and body acceleration without human interference.
ToBBB
Brings drugs to the brain that normally cannot enter the brain. It offers patented central nervous system (CNS) drug targeting technology to partners in pharmaceutical and biotechnology industry.
2QR
Develops a product named 2QR based on aloe vera, that is a watery liquid with little smell or taste and a light amber colour. It can be used as a basis in a variety of products aimed at the prevention and treatment of bacterial overgrowth and the problems related to it.
Xenobiosys
Extracts new biological active compounds for the pharmaceutical and cosmetic industry. Sources for these compounds can be found within the usage of traditional and medicinal plants.
TIFAN, Technology and Industry Fund for Amsterdam and North Holland
The TIFAN fund that was initiated in 1997 with the primary objective of developing industrial, technology oriented and innovative companies in the province of Noord-Holland via the provision of risk bearing capital and management support, as well as, to increase the success percentage of start-up companies.
RTC Ondernemingsfonds
The RTC Ondernemingsfonds was initiated in 1998 with the primary goal of financing innovative enterprises in their pre start-up and start-up phase. The initial capital of this fund is approximately € 2.27 million and the maximum amount available per participation amounts to € 50,000 each. The fund offers share capital and convertible subordinated loans and is an incubator-linked fund.
STIF Seaside Technology and Innovation Fund
STIF BV invests in MBO's and MBI's in the Technology Industry in the Netherlands. Investment terms from Euro 100k - Euro 1 million. STIF started in 2004.
Zernike Seed Fund
Zernike Seed Fund is a Joint Venture of Zernike Ventures, NOM, ABN Amro and Aegon. Zernike Seed Fund invests in early stage companies from € 50k till € 500k. The fund started is 1993 and is accredited by the Dutch National Bank (DNB) as being a private investment company under Dutch Law.